Advocacy Actions
Comments to National Health Commission (NHC) on the Regulatory Measures of Internet-based Diagnosis and Treatment (Draft for Comment)
On 25th November, European Chamber Pharmaceutical Working Group submitted comments to National Health Commission (NHC) on the Regulatory Measures of Internet-based Diagnosis and Treatment (Draft for Comment).
Read moreComments to the "Technical Specification for National Procedures and Services in Medicine" of the Health Development Reseach Institute
The Healthcare Equipment and the Pharmaceuticals Working Group submitted comments to the draft "Technical Specification for National Procedures and Services in Medicine", prepared by the Health Development Reseach Institute under the National Health Commission (NHC).
Read moreComments to the National Development and Reform Commission (NDRC) on Negative List of Market Access (2021 Edition) (Draft for Comment)
The Investment Working Group delivered comments to the National Development and Reform Commission (NDRC) on Negative List of Market Access (2021 Edition) (Draft for Comment)
Read moreComments to China National Intellectual Property Administration (CNIPA) on the Draft Revision of the Guidelines for Patent Examination (Draft for Comment)
The European Chamber submitted comments to China National Intellectual Property Administration (CNIPA) on the Draft Revision of the Guidelines for Patent Examination (Draft for Comment).
Read moreEuropean Chamber Meeting with the National Healthcare Security Administration (NHSA)
On 26th August, the Chair of Pharmaceutical Working Group led a European Chamber delegation to visit the Division of the International Cooperation of the National Healthcare Security Administration (NHSA). The Division director welcomed delegates from the Chamber and expressed appreciations for chamber’s support to the NHSA.
Read moreComments to National Medical Products Administration (NMPA) Information Centre on Printing Requirements for Drug Traceability Identification and Drug Traceability Code Display Specification
The European Chamber submitted comments to National Medical Products Administration (NMPA) Information Centre on Printing Requirements for Drug Traceability Identification and Drug Traceability Code Display Specification.
Comments to the NHSA on the Healthcare Security Law (Draft for Comments)
On 16 July, the medical devices sector sent comments to the National Healthcare Security Administration on the Healthcare Security Law (Draft for Comments).
Read moreEuropean Chamber staff meet with German Embassy Economic & Industry Counsellor
The counsellor of the German Embassy would like to know about the working groups' operation , lobby actions and plans. She is seeking for some common points and mutual support for the advocacy to protect the interest of German business
Read moreChief Negotiator for CAI debriefs European Chamber representatives on the Agreement
On 5th January, Chief Negotiator for the Comprehensive Agreement on Investment (CAI) Ms Maria Martin Prat and her team debriefed a group of Chamber industry representatives on the key points of the Agreement.
Read moreMeeting with National Healthcare Security Administration on Cooperation in 2021
Meeting with National Healthcare Security Administration on Cooperation in 2021
Read more